|Bid||40.94 x 800|
|Ask||41.16 x 1800|
|Day's range||39.46 - 41.97|
|52-week range||39.34 - 107.69|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||87.50|
FRIENDSWOOD, Texas, November 24, 2021--Castle announced oral presentations on its DecisionDx® skin cancer tests at the American Society for Dermatologic Surgery (ASDS) 2021 Annual Meeting.
FRIENDSWOOD, Texas, November 17, 2021--Castle Biosciences announced that it has been named in Inc.’s first-annual Best-Led Companies list.
FRIENDSWOOD, Texas, November 15, 2021--Castle Biosciences has been named a 2021 Houston Chronicle Top Workplace.